DGAP-Adhoc

Siemens Healthineers AG: Q1 results significantly better than market expectations; Outlook for FY2021 raised - Seite 2

- Adjusted EBIT: €78 m (PY: €79 m)

- Adjusted EBIT margin: 18.8% (PY: 19.6%)

Siemens Healthineers Outlook

The managing board decided today to raise the outlook for FY2021 to 8% - 12% comparable revenue growth (from previously 5% - 8%) and to increase the expected adjusted basic earnings per share range to 1.63 - 1.82 € per share (from previously 1.58 - 1.72 €).

The conversion from the additional revenues to earnings per share will be softened by higher expenses for variable compensation and stronger FX headwinds versus the previous guidance.

The outlook was raised based on the ongoing pandemic related demands and a higher confidence in the normalization of the underlying business. The assumption for the rapid antigen test revenues now is for €300-350 million revenues (versus the previous assumption of about €100 million revenues). Given the dynamic of the pandemic, we assume that the pandemic-related demand from Q1 will not persist to the same extent through the remaining FY2021 and beyond. The further assumptions of the previous outlook remain unchanged.

Siemens Healthineers will publish its full earnings release for the Q1 of FY2021 on February 1, 2021.

Please find further explanations regarding our financial key performance indicators in chapter "A.2 Financial performance system" and in the notes to the consolidated financial statements note 29 "Segment information" in the Annual Report 2020 of Siemens Healthineers. The document can be found under the following internet link https://www.corporate.siemens-healthineers.com/investor-relations/pres ... .

 

 

Contact:
Marc Koebernick
Head of Investor Relations
Henkestr. 127
91052 Erlangen
[phone]
[e-mail]

---

26-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

Language:	English
Company:	Siemens Healthineers AG
	Henkestr. 127
	91052 Erlangen
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	https://www.corporate.siemens-healthineers.com
ISIN:	DE000SHL1006
WKN:	SHL100
Indices:	MDAX, TecDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	1163498